All Information (Except Text) for S.2274 - Dextromethorphan Abuse Reduction Act of 2007110th Congress (2007-2008)
|Sponsor:||Sen. Biden, Joseph R., Jr. [D-DE] (Introduced 10/31/2007)|
|Committees:||Senate - Judiciary|
|Latest Action:||Senate - 03/12/2008 Committee on the Judiciary Senate Subcommittee on Crime and Drugs. Hearings held. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
There is 1 version of this bill. View text
All Actions (3)
Committee on the Judiciary Senate Subcommittee on Crime and Drugs. Hearings held.
Action By: Senate Judiciary Subcommittee on Crime and Drugs
Read twice and referred to the Committee on the Judiciary.
Action By: Senate
Sponsor introductory remarks on measure. (CR S13626-13627)
Action By: Senate
|Sen. Grassley, Chuck [R-IA]*||10/31/2007|
|Sen. Durbin, Richard J. [D-IL]*||10/31/2007|
|Sen. Feinstein, Dianne [D-CA]*||10/31/2007|
|Committee / Subcommittee||Date||Activity||Reports|
|Senate Judiciary||10/31/2007||Referred to|
|Senate Judiciary Subcommittee on Crime and Drugs||03/12/2008||Hearings by|
Subject — Policy Area:
One Policy Area term, which best describes an entire measure, is assigned to every public bill or resolution.
- Consumer education
- Drug abuse
- Drug abuse prevention
- Drug industry
- Drug traffic
- Drugs and youth
- Fines (Penalties)
- Government paperwork
- Health education
- Health warnings
- Medical statistics
Latest Summary (1)
Introduced in Senate (10/31/2007)
Dextromethorphan Abuse Reduction Act of 2007 - Amends the Controlled Substances Act to: (1) set forth definitions relating to dextromethorphan in unfinished or finished dosage form; (2) classify unfinished dextromethorphan as a Schedule V controlled substance; and (3) impose civil penalties for sales of products containing dextromethorphan to individuals under the age of 18.
Expresses the sense of the Senate that: (1) manufacturers of products containing dextromethorphan should provide warnings about the dangers of dextromethorphan misuse; and (2) retailers should impose safeguards to protect against the theft of products containing dextromethorphan.
Directs the Director of National Drug Control Policy to make grants to the Partnership for a Drug-Free America and the Community Anti-Drug Coalition of America for education programs to prevent the abuse of prescription and nonprescription drugs (including dextromethorphan).
Authorizes the Administrator of the Substance Abuse and Mental Health Services Administration to make grants to certain communities to implement comprehensive community-wide strategies for addressing abuse of prescription and nonprescription drugs.